Fortis Healthcare · NSE: FORTIS · BSE: 532843
Q1 FY20 results · Apr–Jun 2019
Fortis Healthcare reported revenue from operations of ₹1,138.31 crore (up 9.2% from Q1 FY19) and net profit of ₹78.01 crore for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,138.31 | 1,042.04 | +9.2% | 1,184.15 | −3.9% |
| Other income | 19.56 | 28.51 | −31.4% | 10.00 | +95.6% |
| Total income | 1,157.87 | 1,070.55 | +8.2% | 1,194.15 | −3.0% |
| Profit before share of associates & JVs and tax | 49.47 | (95.64) | Turned profit | 0.44 | 112x |
| Share of profit/(loss) of associates & JVs | 2.82 | 9.00 | 333.33 | ||
| Net profit for the period | 78.01 | (52.80) | Turned profit | 151.18 | −48.4% |
| Attributable to shareholders of the company | 67.81 | (70.74) | Turned profit | — | — |
| EPS, basic (₹) | 0.90 | (1.36) | not comparable | 1.78 | −49.4% |
| Net margin (%) | 6.9 | -5.1 | 12.8 |
This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.
Consolidated
- Filed with BSE
- 07 Aug 2019, 09:10 IST
- Board meeting
- 06 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE